DEME Group NV
DEME Group NV (DEME.BR) Financial Performance & Income Statement Overview
Explore the financials of DEME Group NV (DEME.BR), including yearly and quarterly data on income, cash flow, and balance sheets.
DEME Group NV (DEME.BR) Income Statement & Financial Overview
Explore comprehensive income reports for DEME Group NV DEME.BR, broken down by year and quarter.
Metric | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
---|---|---|---|---|
Revenue | $1.92B | $1.81B | $1.48B | $1.36B |
Cost of Revenue | $1.24B | $1.66B | $1.41B | $1.25B |
Gross Profit | $672.33M | $153.61M | $62.92M | $109.03M |
Gross Profit Ratio | $0.35 | $0.08 | $0.04 | $0.08 |
R&D Expenses | $0.00 | $229000.00 | $0.00 | $0.00 |
SG&A Expenses | $343.003M | $7.81M | $16.56M | $17.31M |
Operating Expenses | $522.12M | $1.34M | $19.37M | $17.31M |
Total Costs & Expenses | $1.79B | $1.66B | $1.43B | $1.27B |
Interest Income | $1.18M | $0.00 | $4.41M | $4.05M |
Interest Expense | $13.40M | $0.00 | $10.13M | $10.77M |
Depreciation & Amortization | $169.31M | $177.29M | $164.76M | $166.99M |
EBITDA | $316.46M | $360.83M | $219.36M | $264.31M |
EBITDA Ratio | $0.17 | $0.18 | $0.14 | $0.19 |
Operating Income | $128.34M | $152.26M | $43.55M | $91.72M |
Operating Income Ratio | $0.07 | $0.08 | $0.03 | $0.07 |
Other Income/Expenses (Net) | $54.03M | $21.82M | -$10.02M | -$5.18M |
Income Before Tax | $182.37M | $173.51M | $44.48M | $86.54M |
Income Before Tax Ratio | $0.10 | $0.10 | $0.03 | $0.06 |
Income Tax Expense | $37.49M | $38.94M | $10.68M | $21.60M |
Net Income | $141.11M | $132.58M | $30.18M | $73.25M |
Net Income Ratio | $0.07 | $0.07 | $0.02 | $0.05 |
EPS | $5.57 | $5.24 | $1.19 | $2.89 |
Diluted EPS | $5.57 | $5.24 | $1.19 | $2.89 |
Weighted Avg Shares Outstanding | $25.33M | $25.31M | $25.31M | $25.31M |
Weighted Avg Shares Outstanding (Diluted) | $25.33M | $25.31M | $25.31M | $25.31M |
Financial performance has remained strong, with revenue growing from $1.36B in Q4 2022 to $1.92B in Q2 2024. Gross profit continued to perform well, with margins at 35% in the latest quarter. Operating income reached $128.34M in Q2 2024, holding a steady 7% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $316.46M. Net income rose to $141.11M, keeping EPS at $5.57. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan